Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002882 | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma | completed | Phase 3 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00006233 | Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 |
| clinicaltrials |
| NCT00006385 | Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 8, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00698100 | Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT00204581 | Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases | completed | Phase 2 | 51 | University Hospital TuebingenOTHER | 1 | Aug 19, 2011 | clinicaltrials |
| NCT00324272 | Post-Operative Drainage Following Lymph Node Dissection | completed | Phase 4 | 74 | Oxford University Hospitals NHS TrustOTHER | 0 | Aug 11, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00399113 | Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
| NCT00734188 | Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 21 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00003646 | Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 78 | VicalINDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00044356 | Phase II Trial of Allovectin-7® for Metastatic Melanoma | completed | Phase 2 | 133 | VicalINDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00580060 | Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity | completed | Early Phase 1 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00658437 | CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy | completed | Phase 2 | 31 | Cytavis Biopharma GmbHINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00471133 | Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | completed | Phase 1 | 24 | Ichor Medical Systems IncorporatedINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00602199 | ABT-510 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 42 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00897624 | Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma | completed | — | 15 | Institut CurieOTHER | 0 | May 13, 2011 | clinicaltrials |
| NCT00003091 | High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | completed | Phase 2 | 40 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00033228 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 19 | Mannkind CorporationINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00261404 | TNFerade™ Biologic Plus Radiation for Metastatic Melanoma | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00615095 | Differential Risks for Melanoma: p16 and DNA Repair | completed | — | 323 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00700167 | Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00680589 | Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00050102 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00881049 | Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma | completed | Phase 2 | 1 | Peking UniversityOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00623402 | Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma(SoraPeg) | completed | Phase 2 | 55 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 12, 2011 | clinicaltrials |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | completed | Phase 3 | 855 | Karolinska InstitutetOTHER | 1 | Dec 14, 2010 | clinicaltrials |
| NCT00651703 | Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients | completed | Phase 2 | 21 | Cytos Biotechnology AGINDUSTRY | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00203008 | A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma | completed | — | 2,106 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Oct 18, 2010 | clinicaltrials |
| NCT00221702 | PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)(EADO) | completed | Phase 3 | 898 | University Hospital, BordeauxOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00045357 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00327600 | Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma | completed | Phase 1 / Phase 2 | 68 | AmpliMed CorporationINDUSTRY | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00609011 | Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma | completed | Phase 1 / Phase 2 | 22 | Myrexis Inc.INDUSTRY | 1 | Aug 23, 2010 | clinicaltrials |
| NCT01183936 | Trial of Surgical Excision Margins in Thick Primary Melanoma | completed | N/A | 936 | Karolinska InstitutetOTHER | 0 | Aug 18, 2010 | clinicaltrials |
| NCT00966173 | International Melanoma Algorithm Training Study - IMATS | completed | N/A | 1,800 | SciBase ABOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00688090 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. | completed | Phase 1 | 19 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00002786 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00045149 | Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | May 7, 2010 | clinicaltrials |
| NCT00197912 | Dendritic Cell Based Therapy of Malignant Melanoma | completed | Phase 1 / Phase 2 | 25 | Herlev HospitalOTHER | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00729950 | Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma | completed | Phase 1 | 92 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00928031 | Long-term Data Collection for Subjects in MDX-010 Studies(MDX010-28) | completed | — | 160 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 26, 2010 | clinicaltrials |
| NCT00765193 | The Impact of Total Body Skin Examination on Skin Cancer Detection(TBSE) | completed | N/A | 14,381 | Medical University of GrazOTHER | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00034554 | Study of gp75 Vaccine in Patients With Stage III and IV Melanoma | completed | Phase 1 | 31 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00289640 | Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma | completed | Phase 2 | 210 | Bristol-Myers SquibbINDUSTRY | 10 | Mar 2, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Dec 13, 2011source: clinicaltrials